BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7706447)

  • 21. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
    Whyte MP
    Nat Rev Endocrinol; 2016 Apr; 12(4):233-46. PubMed ID: 26893260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin B
    Whyte MP; May JD; McAlister WH; Burgener K; Cortez SR; Kreienkamp R; Castro O; Verzola R; Zavala AS; McPherson CC; Gottesman GS; Ericson KL; Coburn SP; Arbelaez AM
    Bone; 2021 Sep; 150():116007. PubMed ID: 34000433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP
    J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypophosphatasia: a cytochemical study of phosphatase activities.
    Goldfischer S; Johnson AB; Morecki R
    Lab Invest; 1976 Jul; 35(1):55-62. PubMed ID: 181638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeatedly low plasma alkaline phosphatase in a 56-year-old woman. A case of hypophosphatasia diagnosed in adulthood.
    Larsen PB; Skausig OB; Jensen EA
    Pract Lab Med; 2018 Jul; 11():19-22. PubMed ID: 30202780
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased plasma pyridoxal-5'-phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia.
    Chodirker BN; Coburn SP; Seargeant LE; Whyte MP; Greenberg CR
    J Inherit Metab Dis; 1990; 13(6):891-6. PubMed ID: 2079838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline phosphatase isoenzymes and clinical features in hypophosphatasia.
    Iqbal SJ; Davies T; Holland S; Manning T; Whittaker P
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():775-80. PubMed ID: 11085622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic characterization of hypophosphatasia mutations with physiological substrates.
    Di Mauro S; Manes T; Hessle L; Kozlenkov A; Pizauro JM; Hoylaerts MF; Millán JL
    J Bone Miner Res; 2002 Aug; 17(8):1383-91. PubMed ID: 12162492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypophosphatasia: biochemical screening of a Dutch kindred and evidence that urinary excretion of inorganic pyrophosphate is a marker for the disease.
    Macfarlane JD; Poorthuis BJ; van de Kamp JJ; Russell RG; Caswell AM
    Clin Chem; 1988 Sep; 34(9):1937-41. PubMed ID: 2843309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
    Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
    Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between serum alkaline phosphatase and pyridoxal-5'-phosphate levels in hypophosphatasia.
    Iqbal SJ; Brain A; Reynolds TM; Penny M; Holland S
    Clin Sci (Lond); 1998 Feb; 94(2):203-6. PubMed ID: 9536930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects.
    Caswell AM; Whyte MP; Russell RG
    Crit Rev Clin Lab Sci; 1991; 28(3):175-232. PubMed ID: 1647780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Hypophosphatasemia in Children.
    Bayramli R; Cevlik T; Guran T; Atay Z; Bas S; Haklar G; Bereket A; Turan S
    Calcif Tissue Int; 2020 Jun; 106(6):608-615. PubMed ID: 32088736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood.
    Khandwala HM; Mumm S; Whyte MP
    Endocr Pract; 2006; 12(6):676-81. PubMed ID: 17229666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS; Rockman-Greenberg C; Rauch F; Bhatti MT; Moseley S; Denker AE; Watsky E; Whyte MP
    Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosylation-deficient mutations in tissue-nonspecific alkaline phosphatase impair its structure and function and are linked to infantile hypophosphatasia.
    Komaru K; Satou Y; Al-Shawafi HA; Numa-Kinjoh N; Sohda M; Oda K
    FEBS J; 2016 Mar; 283(6):1168-79. PubMed ID: 26797772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perinatal hypophosphatasia: diagnosis and detection of heterozygote carriers within the family.
    Gehring B; Mornet E; Plath H; Hansmann M; Bartmann P; Brenner RE
    Clin Genet; 1999 Oct; 56(4):313-7. PubMed ID: 10636450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene Akp2.
    Hough TA; Polewski M; Johnson K; Cheeseman M; Nolan PM; Vizor L; Rastan S; Boyde A; Pritzker K; Hunter AJ; Fisher EM; Terkeltaub R; Brown SD
    J Bone Miner Res; 2007 Sep; 22(9):1397-407. PubMed ID: 17539739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia.
    Gagnon C; Sims NA; Mumm S; McAuley SA; Jung C; Poulton IJ; Ng KW; Ebeling PR
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1007-12. PubMed ID: 20089612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult hypophosphatasia treated with teriparatide.
    Whyte MP; Mumm S; Deal C
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1203-8. PubMed ID: 17213282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.